Drug Profile
Research programme: sodium glucose co-transporter type 2 inhibitors - Chugai
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical
- Class
- Mechanism of Action Sodium-glucose transporter 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Type-2-diabetes-mellitus in Japan
- 25 Aug 2010 Early research in Type-2 diabetes mellitus in Japan (unspecified route)